INVESTOR INFORMATION

Ovagen was established in 2000 as a privately funded R&D company.

Ovagen Group Limited is a privately owned company incorporated in the Republic of Ireland.

There are two wholly owned subsidiaries:
• Ovagen International Ltd. (Patent holding company)
• Ovagen Ltd., (Principle trading company).

UPDATES

If you would like to be notified of updates and progress relating to Ovagen, please enter your email address below. Your email address will not be passed on to any third party companies.

PRODUCT ROADMAP

2000
Concept defined, independent market research and initial investment

Ongoing R&D

2005
Proof of concept (2 genetic lines, >60% hatchability at first derivation to >80% in subsequent generations, fully sustainable breeding cycle)

2006
First press release to coincide with World Vaccine Congress 2006 in Lyon

2007
Extensive market research with large multinational phamaceutical companies confirms value proposition and market size.
Site acquired for new facilities
Detailed design and planning application for Phase I building.
New private investor funding.

2008
Secure investment from external financing/institutional investment for full scale manufacturing and 'go-to-market' strategy. Round I funding for €8m will be completed in April. Identification of strategic partners and Round II funding.
Phase I planning application approved. Construction starts.
Detailed design of manufacturing facilities. Phase II planning application made.

2009
Full scale production as a commercial business
Customer validation of eggs for individual applications

First sales of GF eggs

NEW BUILDING

August 2008 (2500msq)
First generation germ-free flocks,
Isolators, Incubators
Laboratories
Egg processing
R&D
Head Office.

Lower Floor Provides:

• SPF flocks
• Isolators for egg removal
• Large Germ-Free (GF) Isolators
• GF suite for flock of 550 birds
• GF 'space' suits & decontamination showers
• GF feed handling
• GF egg collection & packaging

Upper Floor Provides:

• SPF showers
• Incubating/Hatching Isolators
• Transport Isolators
• Laboratories
• Head Offices